From: Bayesian variable selection for parametric survival model with applications to cancer omics data
Gene symbol | GSE14210 (N = 119) | GSE15459 (N = 197) | GSE29272 (N = 126) | GSE51105 (N = 93) | GSE62254 (N = 283) | Heterogeneity-P (I2) | Combined (random) |
---|---|---|---|---|---|---|---|
CTLA4 (2q33.2) | –a | 0.77 (0.52~1.12) 1.7E−01 | – | 0.45 (0.25~0.82) 7.6E−03 | 0.59 (0.41~0.85) 4.1E−03 | 3.0E−01 16.9% | 0.62 (0.48~0.82) 5.6E−04 |
PLCXD3 (5p13.1) | – | 0.77 (0.51~1.15) 2.0E−01 | – | 1.60 (0.98~2.6) 5.8E−02 | 1.92 (1.32~2.79) 5.0E−04 | 4.0E−03 82.1% | 1.33 (0.75~2.36) 3.3E−01 |
NACAD (7p13) | 1.47 (0.97~2.24) 7.1E−02 | 1.47 (0.93~2.34) 9.8E−02 | 1.61 (1.04~ 2.49) 3.0E−02 | 1.76 (1.06~2.92) 2.7E−02 | 2.03 (1.41~2.92) 9.3E−05 | 7.7E−01 0.0% | 1.68 (1.39~2.04) 1.2E−07 |
SERPINE1 (7q22.1) | 1.46 (0.99~2.16) 5.6E−02 | 0.83 (0.56~1.24) 3.7E−01 | 0.73 (0.48~ 1.10) 1.3E−01 | 1.27 (0.76~2.12) 3.7E−01 | 1.57 (1.08~2.28) 1.6E−02 | 2.2E−02 65.0% | 1.12 (0.82~1.53) 4.7E−01 |
GAMT (19p13.3) | 1.17 (0.81~1.70) 4.0E−01 | 0.69 (0.46~1.03) 6.6E−02 | 1.81 (1.07~ 3.06) 2.6E−02 | 0.54 (0.32~0.92) 2.2E−02 | 1.75 (1.22~2.51) 2.2E−03 | < 1.0E−03 81.8% | 1.08 (0.69~1.68) 7.5E−01 |